Q3 FY2026 · ended Sep 30, 2026 · Revenue $217.61M, -18.7% YoY · Filed Nov 5, 2026
Nutex Health Inc. (NUTX) files with the SEC under industry code 7389, Services-Business Services, NEC. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $217.6 million and net income of $40.2 million. Free cash flow was $73.1 million. As of Sep 30, 2026 it held $249.9 million in cash and investments and $364.9 million in total debt.
Revenue
$217.61M
-18.7% vs year-ago quarter
Net income
$40.23M
-27.4% vs year-ago quarter
Operating cash flow
$78.35M
-21.3% vs year-ago quarter
Free cash flow
$73.14M
-26.3% vs year-ago quarter
EPS
$5.71
-26.4% vs year-ago quarter
Dividend per share
None
Shares outstanding
6.86M
-3.0% vs year-ago quarter
Net cash
$-115.00M
Q3 FY2026
Operating margin
39.0%
TTM
Company profile
- Industry
- Services-Business Services, NEC (SIC 7389)
- Listed as
- NUTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Houston, TX
- SEC filer status
- Accelerated filer
- SEC CIK
- 1479681
- Former names
- Nutex Health, Inc. (until Feb 11, 2026); Clinigence Holdings, Inc. (until Mar 31, 2022); iGambit, Inc. (until Nov 13, 2019)
Other Services-Business Services, NEC companies
- Visa Inc. V
- Mastercard Inc MA
- Alibaba Group Holding Ltd BABA
- Accenture plc ACN
- Uber Technologies, Inc UBER
- PDD Holdings Inc. PDD
- Mercadolibre Inc MELI
- DoorDash, Inc. DASH
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $217.6M | $210.8M | $216.5M | $151.7M | $267.8M |
| Operating income | $77.1M | $121.7M | $81.3M | $30.9M | $130.4M |
| Net income | $40.2M | $65.8M | $46.8M | $11.8M | $55.4M |
| Diluted EPS | $5.71 | $9.38 | $6.52 | $1.74 | $7.76 |
| Operating cash flow | $78.3M | $34.2M | $75.5M | $70.4M | $99.5M |
| Free cash flow | $73.1M | $31.7M | $74.3M | $69.0M | $99.2M |
| Total assets | $1.0B | $964.6M | $957.3M | $918.5M | $964.5M |
| Total liabilities | $491.5M | $457.3M | $515.3M | $495.1M | $526.5M |
| Stockholders' equity | $435.6M | $394.3M | $346.3M | $329.4M | $317.2M |
| Cash and investments | $249.9M | $205.2M | $207.3M | $185.6M | $166.0M |
| Total debt | $364.9M | $347.2M | $348.9M | $350.7M | $353.3M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Sep 11, 2026 | Sep 10, 2026 |
| 8-K | Current report | Aug 31, 2026 | Aug 31, 2026 |
| 8-K |
Current report
Other events
|
Aug 24, 2026 | Aug 24, 2026 |
| 8-K |
Current report
Other events
|
Aug 13, 2026 | Aug 11, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
All 529 Nutex Health Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.